Arnold Schwarzenegger Is Teasing a Mysterious Zeus Project

Arnold Schwarzenegger knows how to reach his fans online. With his acting, sports, and political career, Schwarzenegger often shares his life and workout tips on his Instagram and in his newsletter. But outside of sharing his musings on just about everything, he also teases upcoming acting gigs, including one he just shared on his Instagram.

In a new post, Schwarzenegger is dressed up as an epic-looking Zeus on a promo poster and captioned it “Coming February 2022.” His son, Joseph Baena, also commented jokingly, “Oh god of the sky, please bless my pump today.”

That’s all the info we’ve got. So, what could the mysterious poster mean? Well, according to IMDB, nothing on the actor’s list of upcoming work, including Triplets with Danny Devito, is related to the Greek god. Plus, he didn’t mention a streaming service or TV network related to the post. So, what’s going on in February he could be involved in?

Our best guess is the Super Bowl, which is set to go for February 13. Schwarzenegger could be lending his acting chops (and muscles) to an upcoming TV spot. The whole promotion could be similar to the strange, confusing Crocodile Dundee 2018 Super Bowl ad featuring Danny McBride, Chris Hemsworth, and other Australian actors. Ultimately all the teasers and trailers for the “film” were really a large marketing campaign to increase tourism to Australia.

From the post, it doesn’t look like Schwarzenegger is marketing a product or place. But who knows? Other celebrities could have similar posts up soon, making an epic, mysterious group of Olympian gods for a memorable Super Bowl moment. But like we said, it’s all speculation. By February, the mystery will be solved.

This content is imported from Instagram. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

Milan Polk is an Editorial Assistant for Men’s Health who specializes in entertainment and lifestyle reporting, and has worked for New York Magazine’s Vulture and Chicago Tribune.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Europe's Quest for Earlier Diagnosis of Psoriatic Arthritis thumbnail

Europe’s Quest for Earlier Diagnosis of Psoriatic Arthritis

Please enable cookies. Error 1005 Ray ID: 88e670157d443e22 • 2024-06-04 08:08:55 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 88e670157d443e22 • Your IP: 185.124.111.116 •
Read More
המל"ל מכיר בשורת מחלות כרוניות שהתפרצו בעקבות מחלת הקורונה thumbnail

המל”ל מכיר בשורת מחלות כרוניות שהתפרצו בעקבות מחלת הקורונה

הוועדות הרפואיות של המוסד לביטוח לאומי הכירו לאחרונה בקשר הסיבתי בין פרוץ מחלות כרוניות כמו פיברומיאלגיה, מחלת גרייבס (בלוטת התריס) ומחלות הנגרמות מקרישי דם, כמו פקקת ורידים, כמחלות אשר התעוררו כתוצאה ולאחר הידבקות בנגיף הקורונה. הכרה בקשר הסיבתי שבין הקורונה לבין התפרצות של מחלות שונות היא מגמה חדשה במוסד לביטוח לאומי (המל"ל), אומרים עורכי הדין…
Read More
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer thumbnail

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Oncology/Hematology > Lung Cancer — Half of patients responded, but editorialists call for new directions in therapy development by Charles Bankhead, Senior Editor, MedPage Today June 11, 2024 A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial showed. Overall
Read More
Index Of News
Total
0
Share